TESTOSTERONE CYPIONATE *GS* — Class II drug recall D-0735-2022
Terminated recall by Drug Depot, Inc., dba APS Pharmacy, reported 2022-04-06, distributed nationwide. Lack of sterility assurance.
| Recall number | D-0735-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Drug Depot, Inc., dba APS Pharmacy, Palm Harbor, FL, United States |
| Recall initiated | 2022-03-23 |
| Classified | 2022-03-29 |
| Reported by FDA | 2022-04-06 |
| Terminated | 2023-10-05 |
| Distributed | Nationwide (US) |
| Quantity | 17 vials |
| Reason classes | sterility |
| Lot numbers | 746269 |
| Expiration dates | 2022-06-27 |
Product
TESTOSTERONE CYPIONATE *GS* (2 mL) 80 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 127492, APS Pharmacy
Reason for recall
Lack of sterility assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0735-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.